Navigation Links
Standard Methods Miss 50% of Pharmaceutical Key Opinion Leaders
Date:1/28/2010

Social Network Analysis of 11 disease areas shows that current KOL identification methods produce inaccurate results; relationship models are more effective than bibliometric lists in measuring KOL impact

(PRWEB) January 28, 2010 -- A new white paper challenges the generally-held notion that scientists who are “productive” in terms of publishing are well connected and meaningful to the community. Research firm Lnx Pharma found that in a large number of cases, the opposite was true.

This study questions the current methodology used extensively in pharmaceutical and biotech industries to find Key Opinion Leaders (KOLs) and influential thought leaders. KOLs are a key part of pharmaceutical marketing, discovery and development stages.

“Companies typically use a combination of personal referrals plus standard bibliometrics to find and evaluate candidates for advocacy and advisory roles in drug development,” said Philip Topham, General Manager of Lnx Pharma. “They consider it to be more of an art form than science - qualitative information is layered with publishing counts and speaking engagements data in order to judge the potential value of KOLs. We can now quantify that this methodology is leaving a large number of truly respected thought leaders out of the consideration set.”

Lnx Pharma research shows that bibliometrics as a means of discovering and ranking potential product advocates fails to find over 50% of the truly respected experts, compared to using the more advanced Large Scale Social Network Analysis (SNA). Lnx Pharma is a research company that uses SNA to help pharmaceutical companies to map thought leadership and marketing strategies.

The LS-SNA method was used to evaluate more than 20 different disease state areas including:
        

 
  • Obesity
  •         
  • Blood Coagulation Disorders
  •         
  • Infectious Diseases
  •         
  • Autism
  •         
  • Cardiology
  •         
  • Oncology - Breast
  •         
  • Oncology - Lung
  •         
  • Oncology - Ovarian
  •         
  • Oncology - Colorectal
  •         
  • Rheumatology
  •         
  • Central Nervous System
  •         
  • Diagnostics & Biomarkers
  •         
  • Insomnia
  •         
  • Diabetes
The complex relationships between researchers contain a wealth of information that can be extracted using Large Scale Social Network Analysis. Consequently it is only natural to use research publications to identify experts or key opinion leaders (KOLs.) Yet for all the wealth of information, no amount of counting publications will determine “respect.” A person could publish 10 times or 100 times and still not be respected. And yet, companies continue to utilize this outdated an ineffective technique.

The full white paper may be downloaded from the Lnx Pharma website: http://bit.ly/whitepaper6

About Lnx Pharma
Lnx Pharma is a division of Lnx Research, LLC a privately held company based in Irvine, California, dedicated to leadership in the analysis of knowledge-creating communities. Lnx Research utilizes proprietary social network analysis methods and technologies to identify and understand "The Invisible College" of key opinion leaders in order to answer questions about knowledge communities for government and commercial clients in multiple industries. For white papers on this topic, or more specific information on Lnx Pharma, email info(at)lnxpharma(dot)com, or see http://www.lnxpharma.com.

# # #

Read the full story at http://www.prweb.com/releases/pharmaceutical-marketing/kol-management/prweb3538204.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
2. Standard Management Announces OTCBB Listing
3. Gastroenterology sets standards for CT colonography
4. Public Health and Need for Consistent Standards Preclude Exception for Breastfeeding Mother in National Medical Licensing Test
5. New Drug No Substitute for Standard Blood-Clot Therapy
6. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
7. New guidelines set to improve standard of cows milk allergy care
8. Green Seal Ramps Up Environmental Standard for Household Cleaners
9. URAC CEO Testifies Before New Hampshire Legislators Regarding New URAC Standards for Pharmacy Benefit Management
10. Standard treatment for prostate cancer may encourage spread of disease
11. Health Literacy Innovations Releases New Survey on Medicaid Health Literacy Standards
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Standard Methods Miss 50% of Pharmaceutical Key Opinion Leaders 
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today ... conversation on the current obstacles facing infection prevention and offer strategies for the ... by these infections. , The print component of “Fighting Infection” is distributed ...
(Date:3/24/2017)... ... ... Digital Scientists, a software innovation lab specializing in web design and ... Carolina location. The lab has set up shop at the renowned NEXT Innovation ... Carolina clients for years from our office here in Atlanta,” explains Digital Scientists’ CEO, ...
(Date:3/24/2017)... ... , ... According to a new study by NCPA Senior Fellow John R. ... rules Congress has directed the CBO to follow. The CBO itself previously recognized Obamacare ... it estimates a reduction in employer-based coverage due to the GOP reform, which is ...
(Date:3/24/2017)... , ... March 24, 2017 , ... The iaedp Foundation, ... other medical professionals caring for those suffering from the full spectrum of disordered eating, ... as eating disorders professionals from nearly all 50 states and several countries converged on ...
(Date:3/24/2017)... Arizona (PRWEB) , ... March 24, 2017 , ... ... Healing Center, Sedona, Arizona’s Premier Center for Shamanic Healing and Spiritual Awakening, ... Luis Delgado, June 9--24, 2017. This sacred and spiritual journey during the ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  Twist Bioscience, a company ... today announced that it raised an additional $33 million. ... $166 million. "It is an exciting ... our reach and continue to deliver industry-leading gene volume ... segments," commented Emily M. Leproust, Ph.D., CEO of Twist ...
(Date:3/27/2017)... , March 27, 2017 Arena Pharmaceuticals, Inc. ... on developing novel, small molecule drugs across multiple therapeutic areas, ... Chief Executive Officer, will present a corporate update at the ... 3:40pm ET.  The conference will take place April 4-5, 2017 ... New York , NY.  A live ...
(Date:3/24/2017)... , March 24, 2017 New England Pediatric ... of an award including funding and in-kind service towards ... technology.  "Making blood draws less traumatic ... their whole hospital experience better.  We,re looking forward to ... can help improve care for the kids we treat," ...
Breaking Medicine Technology: